Your institution may have access to this item. Find your institution then sign in to continue.
Title
Rosiglitazone-containing antidiabetes medicines: suspension of marketing authorization.
Abstract
The article reports on a 2010 decision which the European Medicines Agency made to recommended suspension of the marketing authorizations for the rosiglitazone-containing antidiabetes drugs Avandia, Avandamet and Avaglim.